跳至主要内容
临床试验/NCT03685903
NCT03685903Unknown1 期

Prospective Observational Study for the Detection of Duodenal Papilla Using Capsule Endoscopy and Comparison of Images With EUS/ERCP Procedure in Pancreaticobiliary and Periampullary Pathology

Capso Vision, Inc.2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2018年9月26日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
200
试验地点
2
主要终点
The ability to detect and visualize the duodenal papilla

研究概览

简要总结

This observational Non-Significant Risk (NSR) Study will be used to assess the ability of CapsoCam® Plus (SV-3) capsule endoscope to detect the duodenal papilla and visualize pathology or abnormalities in the periampullary area and will prospectively compare the capsule endoscopy and EUS/ERCP pictorial images acquired in procedures conducted in a minimum of 20 and a maximum of 200 research patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males or females at least 18 years of age.
  • Provided written HIPAA Informed Consent in the IRB approved language.
  • Patients indicated for periampullary or pancreaticobiliary examination, with prior cross-sectional imaging (CT/MRI/US/other) performed within past 6 months.

排除标准

  • Patients with existing biliary stent will be excluded
  • EUS/ERCP exclusion criteria: per medical practice, including:
  • Patient refusal to undergo procedure, unstable cardiopulmonary, neurologic, or cardiovascular status; existing bowel perforation
  • Structural abnormalities of esophagus, stomach, small intestine at the discretion of physician.
  • Capsule Endoscopy (CE) exclusion criteria:
  • CE exclusion criteria: difficulty swallowing, pregnancy, known motility issues (gastroparesis), known strictures, gastrointestinal obstructions, fistula or significantly distorted anatomy.
  • Medical history of receipt of surgery, oncologic therapy, or radiation therapy who, in the opinion of the investigator, are at greater risk of capsule endoscope retention.
  • Any other contra-indicated condition as noted on the CapsoCam® Plus (SV-3) Instructions for Use, package insert.

结局指标

主要结局

The ability to detect and visualize the duodenal papilla

时间窗: during capsule endoscopy procedure

Rate of duodenal papilla detection

次要结局

未报告次要终点

研究者

发起方
Capso Vision, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验